On September 19, 2025, China's National Medical Products Administration (NMPA) released the Opinions on Deepening Cosmetics Regulatory Reform and Promoting High-Quality Development of the Industry (Draft for Public Comment). Stakeholders can submit comments to hzpjgs@nmpa.gov.cn by October 10, 2025.
The Draft sets reform goals for 2030 and 2035 and outlines 24 reform measures across 5 key areas, including strengthening innovation support and improving registration and filing efficiency. The proposal has attracted significant attention from the cosmetics industry.
Cosmetics are not only key to meeting consumers'pursuit of beauty but also an important part of improving quality of life. To coordinate high-quality development with high-level safety management, China NMPA has planned a series of reforms to advance cosmetics regulatory modernization and industry growth.
|
Key Areas |
Main Measures |
|
1. Strengthening Innovation Support |
- Streamline registration pathways for special cosmetics with new claimed efficacies - Encourage first launches of new cosmetic products in China - Support products for the aging population - Innovate labeling & personalized services - Strengthen industry support policies |
|
2. Improving Registration & Notification Efficiency |
- Support ingredient innovation - Allow shared safety data for similar products - Enhance technical review & joint national-provincial review - Optimize safety assessment & efficacy claims |
|
3. Strengthening Production and Operation Supervision |
- Implement risk-based classification - Optimize GMP & online sales supervision - Strengthen post-market surveillance & adverse event monitoring - Extend inspections for testing institutions |
|
4. Enhancing Technical Support and Standards |
- Build regulatory talent & capacity |
|
5. Promoting International Alignment |
- Deepen international cooperation |
